• Contact: +91-9643310025, 9643312749
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
    Filter by Categories
    Annual brand plans
    Autoimmune diseases
    Blog
    Conference support
    Corporate strategy and R & D consulting
    KOL support
    Medical
    MSL training
    Orphan Diseases
    Pre-& post launch activities
    Sales & marketing
    Sales force training
Pharmintel

Corporate strategy and R & D consulting

Corporate strategy and R & D consulting

We provide strategic & tactical intelligence support which includes competitor analysis of its R&D strategy, specific product strategy, business development strategy, product differentiation, pricing policies, sales organization etc.
We provide comprehensive coverage of disease or target specific pipelines which includes complete information of all the drugs in development from preclinical/discovery to phase III and available marketed drugs, their analysis based on molecule type, route of administration. Report also contains detailed product/company profiles, licensing information, collaborations & SWOT analysis of most promising drug candidates.
We provide inclusive clinical trial coverage in our reports. We also perform analysis of available clinical trial outcome measures for identifying most promising opportunities.
We provide complete pipeline analysis report for any indication and identify most promising assets for in licensing or possible future threats for existing brands. In indication prioritization reports, we provide most attractive indications insight for drug development, based on biological attractiveness & current unmet medical need for target in question.
We provide performance benchmarking of any pipeline landscape in comparison to current standard of care or potential to address current unmet medical need.
We provide commercial forecast of pipeline drugs. We also provide epidemiology data of any disease in different geographies.
We provide Interactive NPV discount cash flow models to understand product value.
We provide unmet medical need analysis of an indication in the context of pathophysiology, diagnosis, management & prognosis. We map pipeline drugs to current unmet need based on their potential & evaluate residual unmet medical need. It will help researchers to identify target areas for drug development
We provide a comprehensive overview of the healthcare system in terms of pricing and reimbursement process with a detailed analysis of the different regulatory mechanisms used in specific geography.
Therapeutic area market reports contain end to end information of a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It describes disease background, pathophysiology, unmet medical need, pipeline drugs details & SWOT analysis of most promising pipeline drugs.
Contact
+91 9643310025, 9643312749
© 2019 Pharmintel